Lélia Delamarre, Senior Vice President R&D at Medici Therapeutics, shared on LinkedIn:
“I’m happy to share that I’ve joined Medici Therapeutics as SVP of R&D, where I’ll be helping advance personalized immunotherapies for cancer patients.
I’m excited to take on this new challenge and work with my new colleagues at Medici Tx to push the boundaries of cancer immunotherapy and make a meaningful difference in patients’ lives.”
You can also read:
